Impact of COVID-19 disease and its treatment on the development of maxillofacial complications
| Autor: | Najla Dar-Odeh, Dilnoza Bobamuratova, Shukhrat Boymuradov, Yokubjon Kurbanov, Ravshan Z. Umarov |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
2019-20 coronavirus outbreak Maxillofacial Complications RD1-811 Coronavirus disease 2019 (COVID-19) Disease Article medicine Mucormycosis Oral cavity lesions Intensive care medicine Adverse effect Internal medicine business.industry Osteonecrosis General Medicine RC31-1245 Therapeutic modalities Coronavirus Antirheumatic Agents Osteomyelitis of the jaws Underlying disease Respiratory virus Surgery Covid-19 business |
| Zdroj: | Advances in Oral and Maxillofacial Surgery, Vol 4, Iss, Pp 100169-(2021) Advances in Oral and Maxillofacial Surgery |
| ISSN: | 2667-1476 |
| DOI: | 10.1016/j.adoms.2021.100169 |
| Popis: | The novel coronavirus spread worldwide in 2020, causing millions of deaths and disabilities. Even though the virus was considered a respiratory virus, its adverse effects can be detected in several body systems. The article describes COVID-19 disease and its complications in the maxillofacial area. Several complications develop either in response to therapeutic modalities used to treat the underlying disease, or due to overuse of particular medications namely glucocorticoids, antirheumatic agents, interleukin 6-inhibitors, and antibiotics. This article will describe a number of complications ranging from mild complications to severe ones such as osteonecrosis of the upper jaw and facial bones, ophthalmologic and neurological complications. It will also summarize recommendations that will help prevent or minimize these complications. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|